Start with your question. Search first, choose the closest subject and keep personal details private. Posting guidelines
Notifications
Clear all
Nootropics & Cognitive Enhancement
1
Posts
1
Users
0
Reactions
141
Views
Topic starter
08/05/2018 2:14 am
The problem with bromantane discussion is that the anecdote and the mechanism get merged. Here is my attempt to keep them apart.
Loose evidence is not the same as no evidence and people overcorrect in both directions.
Most of the popular protocols are borrowed from clinical populations and applied to healthy people without comment.
The comparison group matters more than the compound when the outcome is something as fuzzy as focus.
If you need three other compounds to notice the first one, you have not tested the first one.
Where does the human data stop and the extrapolation start?